NEW CANAAN, CT—Treatment options for a variety of cancers are expanding to include an array of exciting new approaches. Along with well-established companies, newer biotechnology and biopharmaceutical firms are looking to break into an emerging market that would provide vaccines for both solid cancers—such as melanoma, prostate, breast, lung, cervical, colon, brain, and ovarian—and blood borne cancers—such as lymphoma, leukemia, and myeloma.
NEW CANAAN, CT— Cancer vaccines present an elusive goal, yet one that is increasingly within reach for biomedical researchers. Their hope is to offer physicians and cancer patients more and better therapy options than radiation and chemotherapy.
Leading experts are available to comment on the science and safety of vaccines, and parents are available to discuss what can happen when parents choose not to immunize their children.
NEW CANAAN, CT—Dr. Allan L. Goldstein of the Sabin Vaccine Institute, headquartered in New Canaan, Connecticut, received Panama’s highest national honor during a visit to that country earlier this month. The decoration as “Commander” in the Order of Vasco Nuñez de Balboa was presented to Dr. Goldstein at an awards ceremony on December 6 in Santiago, Panama.
A new study in the November 7th issue of The New England Journal of Medicine shows no association between the MMR vaccine and autism. This study adds significant weight to the extensive body of evidence supporting the safety of the MMR vaccine.
WHAT: The Sabin Vaccine Institute will convene a scientific colloquium, “Global Vaccine Shortage: The Threat to Children and What to Do About It,” where world experts will examine the current problems with maintaining vaccine supplies, and recommend lasting solutions for improving vaccine security.
WHAT: The Sabin Vaccine Institute and GW Medical Center will host a presentation by Patricia Thomas, author of Big Shot: Passion, Politics, and the Struggle for An AIDS Vaccine
Arlington, Virginia – John B. Robbins, who played central roles in the development of vaccines to prevent Haemophilus Influenzae B (Hib), a leading cause of meningitis, and pertussis, has been chosen as the ninth recipient of the Albert Sabin Gold Medal. The Albert B. Sabin Vaccine Institute awards the medal annually to an exemplary contributor to disease prevention.
Abaco, Bahamas, April 13, 1999: Thirty-six scientists gathered on an isolated Bahamanian island last month for three days of off-the-record, freewheeling discussion and debate about cancer vaccine research. They left convinced that the meeting advanced the pursuit of vaccines to prevent and treat cancer. And Elliot L. Richardson, an architect of the “War on Cancer” said he is “excited” by the existence of a vaccine to prevent cancer and the prospect of more.